LCN2 and acute kidney injury: Kidney biomarkers such as NGAL, KIM-1, IL-18, L-FABP (liver-type fatty acid–binding protein), and CysC possess the capacity to fill several knowledge gaps about AKI, including early detection, differential diagnosis, and prognosis.